Specifically, LIGHT activates T cells, while the anti-CTLA-4 antibody reverses the exhaustion state of activated T cells and eliminates inhibitory immune cells, thereby achieving effective control of tumor growth (66). The gene discussed is CTLA4; the disease is neoplasm.